<SEC-DOCUMENT>0001144204-13-033041.txt : 20130604
<SEC-HEADER>0001144204-13-033041.hdr.sgml : 20130604
<ACCEPTANCE-DATETIME>20130603212301
ACCESSION NUMBER:		0001144204-13-033041
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20130603
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20130604
DATE AS OF CHANGE:		20130603

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHAMPIONS ONCOLOGY, INC.
		CENTRAL INDEX KEY:			0000771856
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				521401755
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-17263
		FILM NUMBER:		13889566

	BUSINESS ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205
		BUSINESS PHONE:		410-369-0365

	MAIL ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS BIOTECHNOLOGY, INC.
		DATE OF NAME CHANGE:	20070220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS SPORTS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERNATIONAL GROUP INC
		DATE OF NAME CHANGE:	19860319
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v346872_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES SECURITIES AND EXCHANGE
COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WASHINGTON, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>_________________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM 8-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT PURSUANT TO SECTION 13
OR 15(d) OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported):
<B>June 3, 2013</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CHAMPIONS ONCOLOGY, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-weight: bold">Delaware</TD>
    <TD STYLE="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-weight: bold">0-17263</TD>
    <TD STYLE="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-weight: bold">52-1401755</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">(State or Other Jurisdiction</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">(Commission File Number)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">(IRS Employer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">of Incorporation)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">Identification No.)</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">1 University Plaza, Suite 307, Hackensack,
New Jersey 07601</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices)
(Zip Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Registrant&rsquo;s telephone number, including
area code: <B>(201) 808-8400</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Not applicable</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address if Changed
Since Last Report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>INFORMATION TO BE INCLUDED IN THE REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 5.02.</B></TD><TD STYLE="text-align: justify"><B>Departure of Directors or Certain Officer; Election of Directors; Appointment of Certain Officer; Compensatory Arrangements
of Certain Officers.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Champions Oncology,
Inc. (the &ldquo;<B>Company</B>&rdquo;) today announced the appointment of David Miller, age 44, as the new Vice President, Finance
of the Company. The Company appointed Mr. Miller to replace Gary G. Gemignani, who informed the Company of his intention to resign
as Executive Vice President and Chief Financial Officer on April 22, 2013. Mr. Gemignani has agreed to remain with the Company
until June 30, 2013 to assist in the transition to Mr. Miller.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to joining the
Company, Mr. Miller served as the Vice President of Finance and Operations at DMCWW, LLC, a private equity company focused on investing
and operating start-up enterprises in the consumer technology space. From January 2006 to March 2010, Mr. Miller served as the
Chief Financial Officer of NAF Funding, LLC, a nationwide financial services firm that brokers transactions involving the trading
of life insurance policies. From January 2000 to December 2005, Mr. Miller was the Vice President of Finance and Operations at
IDT Corp., where he led the creation and growth of the consumer phone services division to over one million customers of local
and long distance service. From 1997 to 1999, he was an Assistant Vice President of the Internal Audit Department at Deutche Bank.
Mr. Miller also held Senior Accountant positions at Schonbraun, Safris, Sternlieb, LLC and Margolin, Winer and Evans. Mr. Miller
earned a B.S. from Yeshiva University in 1991 and an MBA from Fordham in 1999. He is a Certified Public Accountant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The terms of the Company&rsquo;s
offer letter with Mr. Miller provide that his salary will be $180,000 per year. He will be eligible for consideration for an annual
bonus equal to 20% of his salary, and his bonus for his first year of employment will be no less than 15% of his annual salary,
paid quarterly. Mr. Miller will be granted (subject to approval by the Company&rsquo;s Board of Directors) an option to purchase
75,000 shares of the Company&rsquo;s common stock under its 2010 Equity Incentive Plan. Mr. Miller will be eligible to participate
in all employee benefit programs implemented by the Company for its full time employees. Mr. Miller&rsquo;s employment is on an
at-will basis. The foregoing description of the offer is a summary only and is qualified in its entirety by reference to the full
text of the offer letter with Mr. Miller, which is attached to this Form 8-K as Exhibit 10.1, and incorporated herein by reference.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 9.01.</B></TD><TD STYLE="text-align: justify"><B>Financial Statements and Exhibits.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><I>(d)</I></TD><TD STYLE="text-align: justify"><I>Exhibits</I></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">The following
exhibit is filed herewith:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><U>Exhibit
No.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left">10.1</TD><TD STYLE="text-align: justify">Offer Letter with David Miller, dated May 30, 2013</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt; color: black"><B>CHAMPIONS ONCOLOGY, INC.</B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">(Registrant)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; width: 30%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; width: 12%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Date: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">June 3, 2013</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><U STYLE="text-decoration: none">/s/ Joel Ackerman</U></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Joel Ackerman</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>v346872_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><IMG SRC="image_003.gif" ALT=""></TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0070C1"><B><I><U>Laboratory
                                                                      </U></I><U>Located at:</U></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0070C1">Science + Technology Park at</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0070C1">Johns Hopkins</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0070C1">855 N. Wolfe Street</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0070C1">Suite 619</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0070C1">Baltimore, MD 21205</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0070C1">Phone: 410.369.0365</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0070C1">Fax: 410.369.0390</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: blue"><U>www.championsoncology.com</U></P></TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0070C1"><B><I><U>Corporate
                                                                      </U></I><U>Office:</U></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0070C1">One University Plaza</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0070C1">Suite 307</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0070C1">Hackensack, NJ 07601</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0070C1">Phone: 201.808.8400</P></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">May 28, 2013</P>

<P STYLE="margin: 0">David Miller</P>

<P STYLE="margin: 0">702 Ogden Avenue</P>

<P STYLE="margin: 0">Teaneck, NJ 07666</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">Dear David,</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify">On behalf of Champions Oncology, Inc., we are pleased
to offer you the position of Vice President, Finance. You will be reporting to Joel Ackerman, CEO at Champions Oncology, Inc.
This letter outlines the terms of your proposed employment as a full-time employee as follows:</P>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD><TD STYLE="text-align: justify"><U>Commencement of Employment</U>: &nbsp;Your employment
start date will be June 3, 2013 Your employment with the Company at all times will be at-will, meaning either you or the Company
can terminate the employment relationship, with or without cause, and with or without notice, at any time. During your employment,
it is expected that you will devote your full business efforts and time to the Company.</TD>
</TR></TABLE>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify"><U>Compensation</U>: &nbsp;Your annualized salary will be
$180,000. Payroll occurs on the 15th and last day of each month. In addition, you will be eligible for consideration for an annual
bonus equal to 20% of your salary. For your first year of employment, your bonus will be no less than 15% of your salary and will
be paid quarterly. The balance of your bonus shall be paid by the Company in its sole discretion. The bonus is only earned and
payable if you are employed by the Company on the date the bonus is scheduled to be paid.</TD>
</TR></TABLE>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify"><U>Champions Oncology Stock Option Grant</U>: &nbsp;Upon
commencement of employment, and subject to approval by the Company&rsquo;s Board of Directors, you will be granted an option to purchase
75,000 shares of the Company&rsquo;s common stock under the terms of the Company&rsquo;s 2010 Equity Incentive Plan and the terms set forth
in the option grant agreement, which will be provided to you after the Board approves your options.</TD>
</TR></TABLE>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify"><U>Benefit Programs:</U> &nbsp;You shall be permitted to
participate in all employee benefit programs implemented by the Company for the benefit of any of its full--]time employees, including,
without limitation, disability insurance, group and other life insurance, sickness, and accident and health insurance programs,
provided that you qualify or are otherwise eligible to participate under the terms of such programs. Except as may be limited
by applicable law, the Company reserves the right to modify, suspend, or discontinue any benefit plans, policies, and practices
at any time without notice to or recourse by employee, so long as such action is taken generally with respect to other similarly
situated persons. In addition, you will be subject to all rules and policies applicable to employees of the Company generally
or at your level or in your position.</TD>
</TR></TABLE>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify"><U>PTO</U>: &nbsp;You will be eligible to begin accruing
Paid Time Off (PTO) the first day of the month following 90 calendar days of employment. PTO accrual, carryover, and payment of
PTO upon termination of employment shall be subject to and in accordance with the Company&rsquo;s PTO policies and practices and applicable
state laws.</TD>
</TR></TABLE>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify"><U>Holidays</U>: &nbsp;The Company offers 11 paid Holidays
to full-time employees.</TD>
</TR></TABLE>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify"><U>Other Reimbursement</U>: &nbsp;Employees who drive their
own cars on business trips are reimbursed using the prevailing Company/IRS mileage reimbursement rate plus costs for parking and
tolls, pursuant to Company policies and practices.</TD>
</TR></TABLE>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify">This offer of employment is contingent upon receipt of satisfactory
references on your behalf, as well as your successful completion of all facets of the Company&rsquo;s pre-employment screening
process, which includes confirmation that you are legally able to work for the Company in the United States in the position
offered to you, and a background investigation. This offer is also contingent upon your signing the Company&rsquo;s Business Protection
Agreement (&ldquo;BPA&rdquo;). A copy of the BPA and background check authorization will be provided to you. Like all Company employees,
you may in the future be required, in the Company&rsquo;s reasonable discretion, to execute agreements relating to other Company
policies or substantive matters.</P>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify">This offer letter supersedes any and all previous correspondence, representation or offer,
whether written or verbal, with respect to your employment with the Company and represents the entire understanding and acknowledgement
between you and the Company regarding your offer of employment with the Company. This letter does not constitute an employment
contract, nor should it be construed as a guarantee that employment or any benefit program or other term or condition of employment
will be continued for any period of time. Any salary figures are not intended to create an employment contract for any specific
period of time and thus your employment, as stated above, is at-will; either you or the company can terminate it at any
time with or without cause or notice. This letter may not be changed or terminated except in writing and signed by the parties.</P>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify">Should you agree and accept the Company&rsquo;s offer, by doing so, you represent and warrant that you are free to accept this offer
of employment and that doing so does not breach or violate any contract, agreement or legal obligation which you have with
any person or entity, including, without limitation, any restrictive covenant (such as an agreement not to compete), notice
period or other obligation that you may owe to any current or former employer that may restrict your ability to perform all
your services for the Company.</P>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify">This offer letter shall be interpreted in accordance with the laws of the State of New Jersey
without regard to the conflicts of laws principles thereof.</P>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify">David, we look forward to you joining the Champions Oncology team.
We believe you will enjoy the challenges and opportunities that lie ahead in our dynamic business and that you have the skills
and talent necessary to be a strong contributor to our mutual growth.</P>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify">To formally accept this offer, please sign, date and return this letter via PDF in an
email to <FONT STYLE="color: #3265FF">s<U>foreman@championsoncology.com</U></FONT> and mail the original to my attention by no
later than June 3, 2013 confirming your acceptance of this offer. Congratulations on your new position, and I look forward to
your contribution to Champions Oncology. If you have any questions please do not hesitate to contact me.</P>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify">Sincerely,</P>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify">&nbsp;<IMG SRC="image_001.gif" ALT=""></P>

<P STYLE="margin: 0; text-align: justify">Joel Ackerman</P>

<P STYLE="margin: 0; text-align: justify">Chief Executive Officer</P>

<P STYLE="margin: 0; text-align: justify">Champions Oncology, Inc.</P>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%">Accepted:</TD>
    <TD STYLE="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt"></TD>
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;<IMG SRC="image_002.gif" ALT=""></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom">05/30/2013</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>David Miller</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;Date</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"></TD></TR>
</TABLE>


<P STYLE="margin: 0; text-align: justify"></P>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.gif
M1TE&.#EA!P%1`/<``/______S/__F?__9O__,___`/_,___,S/_,F?_,9O_,
M,__,`/^9__^9S/^9F?^99O^9,_^9`/]F__]FS/]FF?]F9O]F,_]F`/\S__\S
MS/\SF?\S9O\S,_\S`/\`__\`S/\`F?\`9O\`,_\``,S__\S_S,S_F<S_9LS_
M,\S_`,S,_\S,S,S,F<S,9LS,,\S,`,R9_\R9S,R9F<R99LR9,\R9`,QF_\QF
MS,QFF<QF9LQF,\QF`,PS_\PSS,PSF<PS9LPS,\PS`,P`_\P`S,P`F<P`9LP`
M,\P``)G__YG_S)G_F9G_9IG_,YG_`)G,_YG,S)G,F9G,9IG,,YG,`)F9_YF9
MS)F9F9F99IF9,YF9`)EF_YEFS)EFF9EF9IEF,YEF`)DS_YDSS)DSF9DS9IDS
M,YDS`)D`_YD`S)D`F9D`9ID`,YD``&;__V;_S&;_F6;_9F;_,V;_`&;,_V;,
MS&;,F6;,9F;,,V;,`&:9_V:9S&:9F6:99F:9,V:9`&9F_V9FS&9FF69F9F9F
M,V9F`&8S_V8SS&8SF68S9F8S,V8S`&8`_V8`S&8`F68`9F8`,V8``#/__S/_
MS#/_F3/_9C/_,S/_`#/,_S/,S#/,F3/,9C/,,S/,`#.9_S.9S#.9F3.99C.9
M,S.9`#-F_S-FS#-FF3-F9C-F,S-F`#,S_S,SS#,SF3,S9C,S,S,S`#,`_S,`
MS#,`F3,`9C,`,S,```#__P#_S`#_F0#_9@#_,P#_``#,_P#,S`#,F0#,9@#,
M,P#,``"9_P"9S`"9F0"99@"9,P"9``!F_P!FS`!FF0!F9@!F,P!F```S_P`S
MS``SF0`S9@`S,P`S````_P``S```F0``9@``,P``````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````"P`````!P%1```(_P`!"!Q(L*#!@P@3*ES(L*'#
MAQ`C2IQ(L:+%BP17R%B!L:/'CR!#BAQ)\N`*0*)&`;)2LJ7+ES!CRBP("-FH
M47[^S-S)LZ?/GP*1->/(!="H*C(#!'BYPLJJE1R!2ITJTMDQCB=%`8K)(@_+
ME@'R_.G4C-17JFC33@S0S!G!/Z-DN`RPBE,A3EM)LACE#-"*`V+5"A[,T`I?
M@H`Z^6VI9Q0I&'E4+159(M"Q0P.KC+I"N+-G@2N.D2*H8DL>I"2Y."/%44\>
M)R(/C/KSI."H/),_ZT9[I6S!*GGRD`S`9534*GA0@[PRJI1!0'BB[IX.M,HQ
M9`57=-(YDI0S/9EOA_^T<LRY05+'5%!?[U.SVX)P2:IRIMRZ<)"`_K`X2&H4
M4RO2L<<>"Z*H8E`>QHFT`B=_Y*89;!^5TDP,"(TBBDN`'",*=P*RMX)C!Z:B
MW$<K^)&70%;\006)QQR3&T$!'.-?20$@(V,P`78XG3,S9@0(A"!IMM]`>"3H
M$2FIY#B0"C*6M`)<553!"1XDZ+B>,P9F!\B('JDR&D&C=/+B1<U8DU`5OI$$
M%TLKY+&BE=2I<HQ!3^:AI$4K4/.E0`>H\B9&!_27D&%X&$#2"LA\J1F7<'H6
M)IUBJ4<B->`-U$4J0%XD`X@(`8='254@<Y\*HV3:J&>DJ)(C"7CD(:E'?U#_
M$^!J'WEWUG.CW`J2%:14<8!`FM5VJFZ`.,,90214T<F=%?WAC'2AG7A1`*-D
MB1!ZOW9W569^"#NL9WG0%^`!T+W:41[/$*3''Z96U!^S`%BV9TA,SDN%D=]V
M9L4ST1%T+R`E?!1H-0,=<$R#'1V`QRH)J4#-'_#BV=A]`J6:[V<G]>KCIQ\]
MD<J)@'""B$<K-%.I2:*<'-(3-RD7(\47$^:$*M+&<-28%E%Q#&I[O7>NK`FA
MA[-'FLDE4`!.+!9S9RL8,Z\3HYB+D2JB<(R2M!?Y03!",3032$E_#+6D>$LS
M?=A`@#13Q156`#@M'IVHMX*<$4/D0#,C'T0N=B6A_V<T`%6(4N5#`0Q9]DL!
M_#$O>C?=I`IF#3'K#,3QYOK1*OC^-LK7)!F\)ULNHFT>0AES?KA+HE79U"C-
MK`3((9QPPMI"LG0RBN$"D=`)*0>0QVA%>_%MT`$\ULW0"HED6Y`*HOALF'*A
M<=*%\@59)2/N!W71RND6&;5"6*.T*)U1QZA,YTV<Y$CJ'PBJ_9%A\Q)$7KI\
M#KV08987!-@Q]UGA#,4&T(Q*[K0"'LVF;MXQ'O>X-KE1(&,+-RD(<^:4$!G(
M:%G9P0-<1C&+(.5O((%@06*>D1OZ0:04HC@&)YPAM160HG4":4MN7)C"?F50
M1M7ZVT$LTPQ=+=`A*B`+??\,@`QK@49&\,H##@U2@E1HR(@=X4N.^N,8Z03"
M&*9C"`OTT*)1<`)FH.$+>,02(%)PHD5*RT@>4A+!A+CP&%C[H4.JX(R^`(X4
M60S*MJX5/IR%9G(^M`BU?#80S&51$,>8G$-8X0QD`*-Q7#`(">0@'"<X0X<`
M:,89,X>V8P"#$T=1R"J.$0@%RK$@5!3.292$GBM0;R`%K-9!5&"5^&$D$'BA
M4QKCE4A,(H0%+<)A^)041%<IKB`RF-)-AH8>&<V.='6DT"D)9P55<($34$3E
M3?1C$&".(I(&.<0HC`%&C%#C=L=[QL$<8CT9R2AOR[/=*)ZAPR=Q8D-Q%(A5
MJNC_1O3DDR`R.$0>?]@8CB"#D`:YB?@,PH5$*LDP//IG17CTRH.0YQA=8`@)
M)&2]QE44`*1*28X,`TI.96>?MBP8>FBFD$#\048?/9S!N/-2[+UEA3O+SDH-
M(H-FX`&'IG0('!EB,-$T!!HR^HY"!PHL5:P"DX$ZXS&>$<<#<#&G9VK1[P3B
M@)!QPA@7.F4`C((:)7K+(*K@RQX'PBN3'@T]B@N3+ROR(8FR-9%V%8@*5(%-
M9_Q4%*N(J9R>>==@JLH@>D!/,V(*@,;4,9``^%!)52*1%00U+7143C6W>H!F
M!#,[<N*+\E90#:W)Q2@]2@AC?\.@A;`,E'EM$S"LXE?6_PE`;R$338!6,,J;
M&,-\)U&H,SYZ@$`T+J4`:*LF0?DGAM"%%`ARVWI((0KID&N7A=60_!C'NJC0
M18I-_>!!6`$-!6HFFXA)VTV0"QK7@-4[CD/((?H#1^KMRS$M6H5T`A`(*AYC
ML0>1`>9N@M#(5C-7I!I@Y`"A1%&PL9R>68%6LE.J@V3H.BP42!=(80PO^@$9
M@!"$*9#1O%L%HAE_P"X`Z.(,,S6$5.@5""*0&+ZM1C9\BDOD3T-9D+$:$(X!
ML@8<`U`-SY*"%8(@WS$,(:=F'(0%SP@?,+R$3,P=XBLV@6Q&5)$'3OA!#RMX
M@G76^ID`/,\@0SU0,.%HA<2R3O\/%U5K(EEAD%6DHB^6/8`,9*"'551#OPYY
M`JT0PB,#H0?"`H&.<=#DSE7@K%A]T1GE!F(5ED!CGXTD\#-6,&:#M+5Q=F2K
M*NX<E;V.0IHF64$IJ"A=@2QT-S)@7T57X8PQN7"]GO6L,Z`A"!1!8Q6LL,8A
M[A0`:/1G%:I(E%\=#9$GY7/#G+`&1_KSSU$:BY=6$1Y!9&$,9^QGS*CA;YKB
MQ8IGG/$:9EJ*A)OQ(A;("1I6X`(UJI$7&4PPA`1QAM@.4H7\.(,53U!2('9W
M69_DP0^_2UN.BG64)WAG-?J=X5_^,BAK8.F@I%A%*26BSHP6I!JB,EIC.*32
M+*.H1:K_P.2^/H8:<J%8((%X!@R/)@.GP%DZ!O#LWP)1BJERQ']E"<`!GI'6
M500LW_L>2`""2XJ5S#6RC3'?1?)\A8(K9#9#^]!3E>Y)4NS'S$QM=B"LT`6K
M@Y!'1N.OA>@\$+'L\K[(,%P,K$)R%E2#1\QNNV@*9T!3!L)&7`B$*HQAC%A\
M95__M5$B`UE+MUUA%3;:G`+14P6SR^\*^5$%EV7^C&MH.7*S24B&3A2:\JVV
M)P>`O%F>`(C^E")`C3F&T<C%.CQF9)^6M>P+GV$*[%TTKLCX?$'\)TSPLO49
MM$9&*<)>9-&L0@]8<L8S6KT00*BB54(GZM(MV[848S.M@*!&_REH?7=H5"0`
MC;'Q7JREF21UAA7);L8HK(&S``B9E%8PA(RNH209J+-:H74-]O,,M'4-88<0
M*A`(5M$6&V<02F$_?!((%@=L&F=V,H<@@,`"&P$`!Z"!*S`#I0`W5.0LSV`-
M@,`%`/(KDR%T>I!T$:$">8`'4F,;/N-">04430$(.L@L5_!?=71G*H8BK=<)
M==2`%A4(@/`$&P@1`=`%5V8%$-@09@85%#<1*P!]!I0'>C!VHY`*C0,7/-)T
M8/8]$"@(/401*I!B$5,L9W%ZU,$"3K$*U(<0![`"+&!YIV)9?;8*UK`*T%`-
M@8"$`9=G45@0C/1T#%$%O1*%FB%\5O]BA]-$,DT!(`!2A58H;12A&8@&2WD`
M"*@6B:"H(PAB8T=3!:H@=:&8BKNA`C:D$"636JH8BY_!10I4/+)XBYZQ'3-X
M$'6!A[CXBR1A%+M89U@%C,8H%0BB0.$'"(AXC,[H$G3D$/)F%L]8C3-!1VX8
M62^TB=;8C1\1*@KD<B3GC>08),?PB0IA!7Z0"N78CD%""NB8$'LQCNY8CQ-Q
M7<T()J-0B/;8CPF1!]38$!WFCP09$7G0#-Q($&GEBP5)CBT@"@E):5[3D!2Y
M$%;!CP#P!T[#D!59C1Q&B@,!-835D20).#1C/'\@(B6YDMIX6`L!%W*`D2S9
MCA(68P2!!WAOH`?#.)/^:`UGJ!!=!@@[R9/VR`*=H`H'2"TW0Y0DB0#4T`S'
MTF,P<$\<R93`N&&RI#EN9944&0!>$%%?PQ$S8!3!QY4K:56`P&11)@JD0`HR
@:9;V:`5C!PB!D`/9")=XF9=ZN9=\V9=^^9>Z$1```#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.gif
M1TE&.#EAMP!E`/<``/______S/__F?__9O__,___`/_,___,S/_,F?_,9O_,
M,__,`/^9__^9S/^9F?^99O^9,_^9`/]F__]FS/]FF?]F9O]F,_]F`/\S__\S
MS/\SF?\S9O\S,_\S`/\`__\`S/\`F?\`9O\`,_\``,S__\S_S,S_F<S_9LS_
M,\S_`,S,_\S,S,S,F<S,9LS,,\S,`,R9_\R9S,R9F<R99LR9,\R9`,QF_\QF
MS,QFF<QF9LQF,\QF`,PS_\PSS,PSF<PS9LPS,\PS`,P`_\P`S,P`F<P`9LP`
M,\P``)G__YG_S)G_F9G_9IG_,YG_`)G,_YG,S)G,F9G,9IG,,YG,`)F9_YF9
MS)F9F9F99IF9,YF9`)EF_YEFS)EFF9EF9IEF,YEF`)DS_YDSS)DSF9DS9IDS
M,YDS`)D`_YD`S)D`F9D`9ID`,YD``&;__V;_S&;_F6;_9F;_,V;_`&;,_V;,
MS&;,F6;,9F;,,V;,`&:9_V:9S&:9F6:99F:9,V:9`&9F_V9FS&9FF69F9F9F
M,V9F`&8S_V8SS&8SF68S9F8S,V8S`&8`_V8`S&8`F68`9F8`,V8``#/__S/_
MS#/_F3/_9C/_,S/_`#/,_S/,S#/,F3/,9C/,,S/,`#.9_S.9S#.9F3.99C.9
M,S.9`#-F_S-FS#-FF3-F9C-F,S-F`#,S_S,SS#,SF3,S9C,S,S,S`#,`_S,`
MS#,`F3,`9C,`,S,```#__P#_S`#_F0#_9@#_,P#_``#,_P#,S`#,F0#,9@#,
M,P#,``"9_P"9S`"9F0"99@"9,P"9``!F_P!FS`!FF0!F9@!F,P!F```S_P`S
MS``SF0`S9@`S,P`S````_P``S```F0``9@``,P``````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````"P`````MP!E```(_P`!"!Q(L*#!@P@3*ES(L*'#
MAQ`C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!C5EQQ+9#,
MFS@W6KG&*J?/GQ%7L+IF!:C1HPB'LEJ!M"E2FM><2@4JE.?4AU!M7H48B&G#
MH441TO0Z=46@H=>ND=T:2.M!FCT90EU;<*C;IH%V=@60=NM`J&*5RA7\-FU4
MJ8'2NNWK%\#.N`8?TSVH=+)`M'>-)E9;D/%6R0@5RTUK&2KGIFG#$O2\5?3!
MS0PWJ^YL&*]5@X#][CR,&RS#RI$-0P:ZFW?!G;,1IT:(?&#;T#4/&HY.=;=E
M@:3]8H9.EK7`JL._*__UGG.Y0O*VB3+W#/NXZ]7JC>=4FMD@^J=HUZO_OI<@
MU.2.6;5?3L7%-N!4!4IWH'[!%?7>37-]15U9A@$(0(0*H15>;K?AM)N%"NIF
M7H,,C3A0<WKA!-YU]DTH58(&`:>0=75QMA.++)E8HGQ.30==?05M)E][][$$
M'D3-747369;M]EMBLPFU%`!,WO1A1`]B5&1&0@)YY8PZBI:B3#(^U-Y&6V*$
M%H_8+1B<=X^U:66:T'E$IT45OD9GGB>*Z>9*4$T949P<T00B1E7Q--F1"FTF
M:)M,#87C25]*E"5&B0&947%`ZGB0DP01R:9*&$IT)D>:9K1F8:<EI*%_K"S_
M)26+_8W$YT1WXB2DA:">MZ"?8(ZZ$:,4]>I4HH_VF6QOV2E[88<%F1:>G7]"
MY.E1TW7JXJ<FRI:D@KE21"Q%IS9E&H^)[IBLI``,%5AM(EV+I;#$W=IGM?<&
MV=>WM,FK:EK32F1L4VL"^-]"NPTG98"EK9GJ1<4=:BV^/_GXYH[)-7??=/1:
M%.BD?ST<KH$/7Y0HM)<!O%"I;5IAQ;("%==J1U!.G!"\7'$[\J#9MKBMOF[V
M_*:_B(+L'\K.XI9PB`+E9?%'@2Z8:')FD55FT_;"UZQ,8[9H(<?RX<QQ<I=.
M]!QY3P_TWJ65`KWS2/R&NO5W*>[F5KG3D;5"VQ1)_PI7M,(!SMFX6",M'L"6
M/:=2D3BKO5_C<3_-<<D-[>NBD-N":EA]=NLW:KDE_<WMM.V9!M]:/"'G-,=&
M)[1PW`77*"M:7\],&\PQ&R[29IIFV:NQD,?GX\`3[20G0<C!R1B,R!=)/'P2
M?Q3W7]YM9O6``V=GEN)+FFP5O^[R9=S2I@&8]>'XRI;2?>6*WN9IZG_W-E><
MU7QX3U7*+WR[EZ?.FEFQ2\KY1.(^]X3'+M3SS.:2!I+P(3!ELW,+LF+5E5BM
MA5U;T]"U]D:4QU`.5=?96E8(DI_WP6]^9KH-8QC5K',QQG[\$Q2R5!8@@Q%&
M?*TC(&L(5;BX0&F%9=/(K/^>%1?0B.]^],F=5D:8P-1XQ3>PVIKB7%*5V60P
M3Q@\S-RHU:>BY(9*5L$0Z@YSM0P=Z&`^,2(8[]9!_VFQC1^<R6UF12P4Z4XI
M-')(8@1U%D55K%5?)$S@]&<[FOD1C)&:F5ZV&$6BY)"0AGDD2KX(1L@T*Y)R
MBZ.XMF8\OH2G.`'SSQ0CTD>>:#(E56P>4_88JE-NA%V.8Z3U&N,1-?*/2K!T
M2:;Z%;`"TC(C+`L0#5_"RKK@[I<@(=Y_)-G`0JZ`F<@DUR&-0K1HPNV!1GF>
M-4TR2Z-@<YLJX>%/*`E.E.P1FB=A9#E+\DV?['*=J$2A2:`(3Y2(,R?=K.<\
MIXF03]WI,R1!C$DN_TD27T(HH`055T(Z^9,;)A1NVT)G1YCXT)%(R97<]&=%
M.1(KHQAJHR31*$QJ!=*/)$:B);6F/%,:37*R%*0W>BE+Z2E3D*JSIO^\)TX)
MRKN=;I2F/B7H2H/Z(I$2-9H]/>H_@:K4=0ZUJ9HQ*E0;T[6I@A.&5KWJS[+*
..U:YZ]:M@#:M841(0`#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.gif
M1TE&.#EA.P%I`/<``/______S/__F?__9O__,___`/_,___,S/_,F?_,9O_,
M,__,`/^9__^9S/^9F?^99O^9,_^9`/]F__]FS/]FF?]F9O]F,_]F`/\S__\S
MS/\SF?\S9O\S,_\S`/\`__\`S/\`F?\`9O\`,_\``,S__\S_S,S_F<S_9LS_
M,\S_`,S,_\S,S,S,F<S,9LS,,\S,`,R9_\R9S,R9F<R99LR9,\R9`,QF_\QF
MS,QFF<QF9LQF,\QF`,PS_\PSS,PSF<PS9LPS,\PS`,P`_\P`S,P`F<P`9LP`
M,\P``)G__YG_S)G_F9G_9IG_,YG_`)G,_YG,S)G,F9G,9IG,,YG,`)F9_YF9
MS)F9F9F99IF9,YF9`)EF_YEFS)EFF9EF9IEF,YEF`)DS_YDSS)DSF9DS9IDS
M,YDS`)D`_YD`S)D`F9D`9ID`,YD``&;__V;_S&;_F6;_9F;_,V;_`&;,_V;,
MS&;,F6;,9F;,,V;,`&:9_V:9S&:9F6:99F:9,V:9`&9F_V9FS&9FF69F9F9F
M,V9F`&8S_V8SS&8SF68S9F8S,V8S`&8`_V8`S&8`F68`9F8`,V8``#/__S/_
MS#/_F3/_9C/_,S/_`#/,_S/,S#/,F3/,9C/,,S/,`#.9_S.9S#.9F3.99C.9
M,S.9`#-F_S-FS#-FF3-F9C-F,S-F`#,S_S,SS#,SF3,S9C,S,S,S`#,`_S,`
MS#,`F3,`9C,`,S,```#__P#_S`#_F0#_9@#_,P#_``#,_P#,S`#,F0#,9@#,
M,P#,``"9_P"9S`"9F0"99@"9,P"9``!F_P!FS`!FF0!F9@!F,P!F```S_P`S
MS``SF0`S9@`S,P`S````_P``S```F0``9@``,P``````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````"P`````.P%I```(_P`!"!Q(L*#!@P@3*ES(L*'#
MAQ`C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSA3DMC)LR?/G$"#"AU*D,0*)W+FY.G$M"G3/'F</%E!M*K5JR9)J-CJ9,Z<
M2Y>"B1U+MI/7)TZVDL#*MJW;ASSG."5+MZ[83J,Z<9+C9.?;OX"Q[GPBMY/=
MPXC',KV4=FW@QY!E[E3!-+'ERW<[]8W,N?-)$FTN&<9,VG*G/"H\JU[-D823
ML,=*RT[,US'KV[@=DI`[NW?BTRILYQX^?*>3T;Z3'^YT23CQYYY)R*FLO/KR
MS="S0R:QU+KWY7.<:_\?C_7X]_-U-8LGSQZH:^3HXP?K]&1]^_LS5727SW]^
M>/P`TD19?P2*-<<3`2;H$G<%%G@,:@I&F))Y#?8W2A[V2:AA:V%5R)]Z&X8(
M$E(>?IB:B"AR-"!Z3LGQQ(LP>B4:?+UU<F**.%[$((MIJ6403RH@19ULFN5H
MI$4K6M=4%3<RA-1^I)F5X9%4(K3;=YW4)M%D35T&8I5@-I1D<E)B9!R-=-D8
MYIH+C5DC:E-N.9U=:K)IIT$&N$GD$TUN)!V-1=XIZ$`J5(%F:1B&I!]R90XJ
M*'>'1MFG1^_-AYVC=^I96ITDZ3<IIF&2$*F7$'X&ZJ"B^C9*?:>VVNFHOWW_
MZNJL&CV1W*6TYIH1"9;XUDF<N@:K&ZS7452"$DI`40<4R)90@K"MICH;IQ`I
M6\>UV%X+Q;/08JJI98E&5$*VY%ZKA+/=/FKKM`A"M(*UY9:[;44^]9203U;^
MU)"]#.%[+[\_U@OP00,K)+!N^@:<,,$'OT1"AT0"2]"X\59<1Q3<0J35C$XQ
MA:M`D#XE7F%,`7M<4TXL%++'ZZU,'U5%==PQ8\']Z%0>!@LI\QPU6XE'4Z46
M13*U`[TG,WT2*\I)C4D#0+'%%4.AL0J\+?<ER!"'2U`>BL4YYJ\&PW>:>$_`
M)T>?TB(&7$%ISY$09:.R3+`<9:$]QRYW39HVG6FQ__2MVG@T#?7@&:M<&*FV
M/3R6U@-Q?9?78LL*,J`IQTS7V6P3*Q;C;2/T=UGMLDTW656P?7?>;#MQ&>8K
M?6X7'E0\]/3@\1:ND)L=EZ6UXIN+Y_A\4Y)0=EF56PFH'`6YR7K1C.;>M>4&
MSIWF7&3])SI=00.P&][SH3UZ9EU:*OE(KM>U/$.STT[NO`Q5/5\>3!I511ZC
M6"H<[\$P+M#O8"?T!,3/,UYZ$C<'\Z$-.3Q;09#<%PPD0"\8;DN=V/K"I;K]
MZ'MW*9[V3M>]Y#&J/JXQ3W-:4KZRG&\A*U"?Q6Q',$9MA6V>^E'6?!?`%BJF
MAC:SRP@!0"&RG%!:@1I(#_]WJ#T$L@U*G6"2Z5QXO31A9WNH(\B*+B&'^UG/
M;_7;U,<2DCX59HN%!BG@6")(,()U:&RFPV%!**09!-IG;XI)C:9^.)H@3JZ&
MG7N@'8NRGRPU23IT@A`4.RA%%S:M)"K(8I0TN)`N>O%:Z+H7$S5VQJBLX)*7
M[&'_<BB6YD",:,Q3#'+R\*+1R.%[=,Q@YO!H1(+TL(H)<8+CS`(SD&$0@!@:
M)-&^1LI#BB211&*D0ASYR'.%38W].J-9O,),]VW2@V/<S1EKN<K-]=$K&:10
M*BT%S<>%,GJN1,X6"46A`Q7E>V:IFR[[I)\T':@Q+P&F%F7WR-J!\9O`BPC^
MO&3_GQ6!K5(OLZ&!@H2F\&CS@!GTB1@W]T`R"@2=D+O+[M#9PV#TA8.@U%-3
MKM@Z16+F:HVL9[GNB<]G[@N`IFD9HQSC3_T5<7%;`=29Q++-^7!"+S>U(#X=
M"@"(MFF4B8-HDC3SE2AZ<$C$\^5&2JB8OC6D!/`2:1U(>D=O4K(L,BN+2L<H
M%2>\)HZ<S)\<X5.Y@U93;5FZ7RL',B="6HE"E[@B(+VIR:*ZE6TK>,)T`.52
M1&J.>.,K"#'5QSY)(E-EG^S15A:(S"N),GR+<T[:2K70'9KU@72*WUEYVD..
M)J^<H=.>3_=)'5#"L"MB4VI&F)K!P!9$JMKJ%_^$B5B)_XZLCN+9YV\D.\H3
M#0^"CKDL/N=C&*"IP`!AY6G:B&@06=YE*N=\GC3IY%J!$&:2*6$M36F;D*@^
MDJI"U"D,<SM#@_!//$PUZ61/)*J2"=&4".UD5\[B%X%"\(A-_=10<377?&JO
MHD8M&JM2IYC0GD0%2YM6TP8+-6H>LZE^F<Q>^5O>@IPW>>@\&GP,O-ZB>36<
M-(TOB("51X*L8*$L6TL%8=I$_PH$=V@[#F/JI;H`?P:E'SWDN#3A1:D]Y&N=
MP(,<EL(HN59X:SB$5$+K-52ULCB6\*WF'A]\7X/@#@]81BHH^VO2&H/5PW5D
MSBG!4L>^DJ2_\X0(5`D;R8<X]_\RI"S*D1N'PR3!\B!MI<\#L]?<*$-ORH8%
M9Y_3DQ[:<MDY7_LC@-.C1)8LVC3($Y=WY05>SST:=-3$GTLO_%Y5(J2SB>NM
M0LHI8N[:U[,@@])R^GIH_'ZY:+];SG%;`L<<2Z0$+*B#)GB\ODK?#JFBG!3<
M1&9>W,*ZN";EHT1OM*.U(<0`Y@GHGR.]KSHR5VC`EFBC+S@:ERZJN'K;*YI`
MJI):>ZFZ!W%6"=ZUK39;9"=>80HGO-*SU+WHPU:&$2.E\J(X>15&PODW6H('
M<+(!'"+\1HO*@B1N2U`P9S`R<-%4<'""+9`I](4)KWREVI+X"U0%0\G"8++0
M8*;KY!#_^>UL[HSRE@=Z6N-TN<O-_5$^CZ3C,B>.=M.$;HS$D";KAH+0W>VT
M=1=NW>E^%PM8P,)UOVL%8+SD,"^I!*C?T^E0@'H`!H))P4*=/30GC9E;P[6Q
MJZ0$4;!#M@H+`&OY6"!#-_&DWPZ`7)/+F`.AV-7C17>X[X%<46"!0'2]K+Q#
M$NRJACGYAH<TF2C!#KPF//O&E8E,3%4@>L^[LB*OZ[<'``J<YS'>G;;K>RI!
M$Y:_UJXOKWE09,OR/M:U)N8%51[?1P48K%',?8Y$FY\=6\Y2`K9H_T7,'UX@
M*>P\5)65!($$P.Y08#J\FF]\U@OV6G38EO"O%86M.\WMVU(6_]Z?YBRA6Y\]
M.T^3[]_]:-.>Q/R%W?'ETW>NS#L-^$4Q_%2]#X#DU\$Q]C<Q4;`L&4-^U1=)
MZD80\&>`^)%^3H1S17%I-G82:W9^;1=;3^-V]L>`@A6`]W=\'GB`!0%_10>"
M62=T$T,NOE8<./8F3D41\Z,Y9A<2'`AW&(@M[Z(M((A_!G$LQU=]K!>"'V@[
M.5A_PN=C\O>#'UAX`>)8WA$5]88P$I@F`X82-7B!A4=^WL4M5XAY'LB`0AB"
MUJ($)8B$A*>$%)-U"A)VT^)'P9$A/$$8HD$DZR<2&FAX//8LY%>!.ZB$_/>%
M/!B&D%2`UL*%(%B#%,,"!Q`A#HA6&/\G%4G@+$G@51RC'.Y'@]O7;A5(?'UH
M??!B=<)'AM^G+58W?/IG=5)7?4/'AUSH=J6(AM>2B@KR/PWB/%C2<QKA@^6R
M`L@UBM:7?(18,?I'+ME7@+4S$)-&@"G(=T<7BPX&(,+3@B52'3/H$>47!=C(
M=@!PA`68+$=W+%`P@,QR=,ER,>,H',LG=(68=\B"C5&0=4U7CN\(CP:1+,_8
MA"4WC=[1>"G!`NKXC.!8$,F2;O_8=.RFC<BGCNKXC<FBA@@1=$)WC]O8=Q'"
MAOHX+:A&$@'`?SEG$XUXD71A3AVI((L"DLJ1D2-Y'\+S5R89DA"8DJRQ(RT9
M)1('DP'RD15_(C<VJ2$KZ5$SF50[B2*5\I.*<6U!&2(J((WZ2&Y'*2(J!Y(8
M]Y)-"1WP-H=+"4]3>223894%HI-9&2K"<SCG@3)1^)5K,AE?I22D]$)F"7)/
M0&20]1LW`UUMZ2IQ2!A#<S2<`"-O6)?=(C#UXI>".9B$69B&>9B(F9B*N9@!
#`0`[
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
